跳至主要内容
临床试验/EUCTR2006-000954-31-FI
EUCTR2006-000954-31-FI进行中(未招募)不适用

Centralised Pan-European Survey on the Undertreatment of Hyperchlesterolemia - CEPHEUS

AstraZeneca Oy0 个研究点目标入组 20,900 人开始时间: 2006年3月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
20,900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Subject must be 18 years of age or older of either sex and of any race.
  • -Subject must demonstrate his/her willingness to participate in the survey and comply with its procedures by signing a written informed consent.
  • -Subject is on lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Subjects who are unwilling or unable to provide informed consent.

研究者

相似试验

Centralised Pan-European Survey on the... | 临床试验